Global Companion Animal Arthritis Market Projected to Reach $6.6 Billion by 2030 at 10.2% CAGR

April 8, 2026April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Alpha Mannosidosis Market Projected To Become By 2030 Based On Its 2026 Valuation?

The companion animal arthritis market has experienced significant expansion in recent years. This market is projected to grow from $4.07 billion in 2025 to $4.48 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.1%. Historically, this growth can be attributed to an increase in companion animal ownership, the extended lifespans of dogs and cats, rising awareness of pet joint health, the expansion of veterinary care infrastructure, and the availability of anti-inflammatory medications.

The companion animal arthritis market size is set to experience substantial expansion over the next few years. It is forecast to reach a valuation of $6.62 billion by 2030, achieving a compound annual growth rate (CAGR) of 10.2%. This anticipated growth during the forecast period stems from factors such as increasing pet humanization trends, a rising demand for advanced arthritis therapies, an expanding senior pet population, the proliferation of online veterinary pharmacies, and breakthroughs in combination therapies and supplements. Significant trends foreseen in this period include a growing prevalence of age-related arthritis in pets, increased spending by pet owners on chronic care, wider adoption of nutraceuticals and joint supplements, a move towards early diagnosis and preventive treatment, and a heightened need for long-term pain management solutions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7772&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Alpha Mannosidosis Market?

The increasing rate of pet adoption is anticipated to fuel expansion within the companion animal arthritis market. Pet adoption involves assuming care for an animal from a shelter or prior owner, encompassing the provision of nourishment, shelter, and overall well-being. The surge in pet adoption stems from heightened emotional consciousness, with individuals increasingly seeking companionship and mental solace through animal care. Treatments for companion animal arthritis facilitate pet adoption by assuring prospective owners that age-related joint problems are manageable, thereby simplifying the care of older pets and enhancing their chances of adoption. An example highlighting this trend is seen in 2024, where data from the US-based nonprofit Shelter Animals Count (SAC) indicates that dog adoption rates (calculated as a percentage of adoptions against intakes) rose from 56% in 2023 to 57% in 2024. Consequently, the escalating trend of pet adoption plays a crucial role in fostering the expansion of the companion animal arthritis market.

What Segment Groups Are Identified Within The Alpha Mannosidosis Market?

The companion animal arthritis market covered in this report is segmented –

1) By Type: Dogs, Cats, Other Types

2) By Indication: Osteoarthritis, Inflammatory Arthritis

3) By Treatment: Medication, Supplements, Other Treatments

4) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, Online Stores, Other Distribution Channels

Subsegments:

1) By Dogs: Large Breed Dogs, Small Breed Dogs, Senior Dogs

2) By Cats: Domestic Cats, Senior Cats

3) By Other Types: Rabbits, Ferrets

What Trends Are Advancing Progress In The Companion Animal Arthritis Market?

Companies within the companion animal arthritis market are increasingly concentrating on technological breakthroughs, including sophisticated therapeutic items and supplements, to offer effective pain relief and better joint health for pets, thereby enhancing the life quality for older and arthritis-afflicted animals. Bonqat represents a novel medication specifically for cats, designed to alleviate anxiety during stressful events like travel or veterinary appointments, without inducing drowsiness. Its objective is to soothe cats, simplifying experiences such as journeys or medical visits for both the animals and their owners. For example, in April 2024, Zoetis Inc., a US-based firm producing medicines and vaccinations for animals, introduced Bonqat (pregabalin oral solution) to mitigate acute anxiety and fear in felines linked to transportation and veterinary visits, factors that often impede regular care. This oral solution can be combined with food or given straight to the cat, simplifying the administration process for pet owners. The dosage is minimal (0.1 mL/kg), and most cat owners have indicated that administering it is straightforward.

Which Companies Hold Significant Positions In The Alpha Mannosidosis Market?

Major companies operating in the companion animal arthritis market are Zoetis Inc., Merck Animal Health, Boehringer Ingelheim, Bayer Animal Health, Vetoquinol, Ceva Santé Animale, Dechra Pharmaceuticals, PetMed Express, Pet Health Solutions, VetriScience, Canine Arthritis Management, Integrative Pet Care, The Honest Kitchen, Vetri-Science Laboratories, Anivive Lifesciences, Nutramax Laboratories, Hill’s Pet Nutrition, Royal Canin, Medivet, Virbac, Canna-Pet, Lintbells, Allivet, Petlab Co.

Read the full companion animal arthritis market report here:

https://www.thebusinessresearchcompany.com/report/companion-animal-arthritis-global-market-report

Which Regions Are Projected To Dominate The Alpha Mannosidosis Market In The Coming Years?

North America was the largest region in the companion animal arthritis market in 2025. The regions covered in the companion animal arthritis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Alpha Mannosidosis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7772&type=smp

Browse Through More Reports Similar to the Global Companion Animal Arthritis Market 2026, By The Business Research Company

Canine Arthritis Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

Companion Animal Pharmaceuticals Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/companion-animal-pharmaceuticals-global-market-report

Animal Health Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-health-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795